These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 8391242

  • 1. Prognostic significance of p53 protein expression and DNA ploidy in surgically treated non-small cell lung carcinomas.
    Mørkve O, Halvorsen OJ, Skjaerven R, Stangeland L, Gulsvik A, Laerum OD.
    Anticancer Res; 1993; 13(3):571-8. PubMed ID: 8391242
    [Abstract] [Full Text] [Related]

  • 2. Evaluations of p53 immunoreactivity, nucleolar organizer regions, and proliferating cell nuclear antigen in non-small cell lung carcinoma.
    Oyama T, Osaki T, Nose N, Ichiki Y, Inoue M, Imoto H, Yoshimatsu T, Kodate M, Uramoto H, Mizoue T, Yano K, Yasumoto K.
    Anticancer Res; 2000; 20(1B):505-10. PubMed ID: 10769714
    [Abstract] [Full Text] [Related]

  • 3. Relationship of p53 overexpression and up-regulation of proliferating cell nuclear antigen with the clinical course of non-small cell lung cancer.
    Ebina M, Steinberg SM, Mulshine JL, Linnoila RI.
    Cancer Res; 1994 May 01; 54(9):2496-503. PubMed ID: 7909277
    [Abstract] [Full Text] [Related]

  • 4. Prognostic value of nuclear DNA content and expression of the ras oncogene product in lung cancer.
    Miyamoto H, Harada M, Isobe H, Akita HD, Haneda H, Yamaguchi E, Kuzumaki N, Kawakami Y.
    Cancer Res; 1991 Dec 01; 51(23 Pt 1):6346-50. PubMed ID: 1657384
    [Abstract] [Full Text] [Related]

  • 5. The utility of p53 immunostaining of transbronchial biopsy specimens of lung cancer: p53 overexpression predicts poor prognosis and chemoresistance in advanced non-small cell lung cancer.
    Kawasaki M, Nakanishi Y, Kuwano K, Yatsunami J, Takayama K, Hara N.
    Clin Cancer Res; 1997 Jul 01; 3(7):1195-200. PubMed ID: 9815799
    [Abstract] [Full Text] [Related]

  • 6. Prognostic significance of the tumor suppressor gene maspin in non-small cell lung cancer.
    Hirai K, Koizumi K, Haraguchi S, Hirata T, Mikami I, Fukushima M, Yamagishi S, Kawashima T, Okada D, Shimizu K, Kawamoto M.
    Ann Thorac Surg; 2005 Jan 01; 79(1):248-53. PubMed ID: 15620951
    [Abstract] [Full Text] [Related]

  • 7. Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.
    De Petris L, Orre LM, Kanter L, Pernemalm M, Koyi H, Lewensohn R, Lehtiö J.
    Lung Cancer; 2009 Mar 01; 63(3):410-7. PubMed ID: 18620780
    [Abstract] [Full Text] [Related]

  • 8. p53 protein in non-small cell lung cancer as quantitated by enzyme-linked immunosorbent assay: relation to prognosis.
    Pappot H, Francis D, Brünner N, Grondahl-Hansen J, Osterlind K.
    Clin Cancer Res; 1996 Jan 01; 2(1):155-60. PubMed ID: 9816102
    [Abstract] [Full Text] [Related]

  • 9. Cluster analysis of p-glycoprotein, c-erb-B2 and P53 in relation to tumor histology strongly indicates prognosis in patients with operable non-small cell lung cancer.
    Bozcuk H, Gumus A, Ozbilim G, Sarper A, Kucukosmanoglu I, Ozbudak IH, Artac M, Ozdogan M, Samur M, Kaya A, Savas B.
    Med Sci Monit; 2005 Jun 01; 11(6):HY11-20. PubMed ID: 15917726
    [Abstract] [Full Text] [Related]

  • 10. [Studies on flow cytometric analysis of nuclear DNA content in non-small cell lung cancer].
    Isobe H.
    Hokkaido Igaku Zasshi; 1991 Jan 01; 66(1):49-58. PubMed ID: 1848524
    [Abstract] [Full Text] [Related]

  • 11. Expression of nuclear factor-kappaB and its clinical significance in nonsmall-cell lung cancer.
    Zhang Z, Ma J, Li N, Sun N, Wang C.
    Ann Thorac Surg; 2006 Jul 01; 82(1):243-8. PubMed ID: 16798222
    [Abstract] [Full Text] [Related]

  • 12. [The prognostic significance of nuclear DNA content in non-small-cell lung carcinoma].
    Yamaoka N, Uchiyama Y, Kimino K, Akamine S, Matsuo S, Tsuji K.
    Nihon Geka Gakkai Zasshi; 1990 Oct 01; 91(10):1608-16. PubMed ID: 2175839
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prognostic significance of flow cytometry in non-small-cell lung cancer.
    Rice TW, Bauer TW, Gephardt GN, Medendorp SV, McLain DA, Kirby TJ.
    J Thorac Cardiovasc Surg; 1993 Aug 01; 106(2):210-7. PubMed ID: 8393505
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Neural networks as a prognostic tool for patients with non-small cell carcinoma of the lung.
    Bellotti M, Elsner B, Paez De Lima A, Esteva H, Marchevsky AM.
    Mod Pathol; 1997 Dec 01; 10(12):1221-7. PubMed ID: 9436967
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.